Low doses of steroids can help myeloma patientsAccording to results of Eastern Cooperative Oncology Group Phase III clinical trial E4A03 for multiple myeloma, patients with multiple myeloma can experience dramatically improved results when they are administered with a combination of lenalidomide and low-dose dexamethasone therapy when compared to a combination of lenalidomide plus high-dose dexamethasone.

This finding was reported by S. Vincent Rajkumar, M.D. at the American Society of Hematology‘s annual meeting.

Dr. Rajkumar, Mayo Clinic Cancer Center hematologist and lead investigator of the study, noted that it is surprising to know that side effects are increased and survival rate is reduced when high doses of steroids are administered.